NYSE:SER | Free Cash Flow | Serina Therapeutics, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2017-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$4.57M$25,000.00-$4.59M
2025-12-31-$6.03M$0.00-$6.03M
2025-03-31-$4.32M$0.00-$4.32M
2024-12-31-$4.59M$5,000.00-$4.59M
2024-03-31-$1.58M$14,000.00-$1.59M
2023-12-31$121,000.00
2023-03-31-$709,000.00
2022-12-31-$1.32M
2022-03-31-$1.64M
2021-12-31-$1.65M
2021-03-31-$2.63M
2020-12-31-$1.62M$0.00-$1.62M
2020-03-31-$2.06M$4,000.00-$2.07M
2019-12-31-$2.41M$295,000.00-$2.71M
2019-03-31-$2.62M$3,000.00-$2.62M
2018-12-31-$2.05M$0.00-$2.05M
2018-03-31-$2.01M$1,000.00-$2.01M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$17.96M$59,000.00-$18.01M
2024-12-31-$17.14M$22,000.00-$17.16M
2023-12-31-$2.48M
2022-12-31-$5.94M
2021-12-31-$7.86M
2020-12-31-$7.82M$20,000.00-$7.84M
2019-12-31-$10.16M$641,000.00-$10.8M
2018-12-31-$8M$21,000.00-$8.02M
2017-12-31-$6.29M$1,000.00-$6.29M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.